Secukinumab biosimilar (Luye Pharma)

司库奇尤单抗生物类似药 (绿叶制药)

Report date: 2024/04/23 09:52:12

Base Information

Drug NameSecukinumab biosimilar (Luye Pharma)
Drug Alias NameTS-1808
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsPsoriasisSpondylitis, AnkylosingArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPsoriasisSpondylitis, AnkylosingArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A